News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neuros Medical, Inc. Receives Regulatory Approval to Commence Pilot Study



11/29/2011 9:22:26 AM

CLEVELAND--(BUSINESS WIRE)--Neuros Medical, Inc., a medical device company announced it has received an Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration allowing it to commence a pilot clinical trial to evaluate the Company’s patented high frequency Electrical Nerve Block™ technology for use in acute treatment of pain in the residual limb of amputees. The IDE approval builds off of the Company’s successful first-in-man feasibility study earlier this year, in which four out of five patients reported significant pain reduction, at times reducing pain scores to zero. The feasibility study was the first human test of the Company’s high frequency Electrical Nerve Block technology and focused on patients with chronic amputation pain which affects nearly one million patients in the U.S.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES